Nordion Ships The First Mo-99 Sample From Russia.

Nordion Inc., a major company providing services and products to healthcare market across the world, announced that the first sample of its Molybdenum-99 (Mo-99) has been shipped from "Isotope", Nordion’s partner in Russia. Mo-99 and other Medical isotopes are used by a wide range of hospitals and healthcare facilities in order to diagnose and treat several medical conditions, such as cardiac and neurological disorders in addition to several forms of cancer.
Back in September, Nordion and Isotope made a supply agreement for Mo-99 that extends until 2020. The recently-shipped sample will be evaluated at Nordion’s facility in Ottawa, Canada. The assessment is taking place in order to get product registration and regulatory approvals before allowing Nordion to start supplying the medical isotope in the Canadian markets.

To read of this news, please visit:

Nordion Ships The First Mo-99 Sample From Russia.

New York Times Reported Uncomfortable Questions On Breast Cancer Screening Guidelines.

According to New York Times, debates have been taking place since the release of breast cancer screening recommendations over than one year ago; it was reported that there are still "lingering, uncomfortable questions about when and how often to undergo breast cancer screenings, and how to balance the benefits of early diagnosis with the harms of mammography”.

New guidelines were released by the U.S Preventive Services Task Force in November 2009, mentioning that females with an average risk of breast cancer should start imaging for the disease at age 50 other than females at age 40. The panel recommendations mentioned that the decision to begin imaging every two years "should be an individual one" that "takes patient context into account, including the patient's values regarding the specific benefits and harms."
In order to read the rest of the article please visit:
New York Times Reported Uncomfortable Questions On Breast Cancer Screening Guidelines.

EMRs Do Not Always Mean Higher Quality Of Care, Study.

A new research, published this week in the American Journal of Managed Care, found that the adoption of electronic medical records (EMR) in U.S. hospitals has limited effect on the quality of care.


The researchers at the nonprofit Rand analyzed the quality of care at 2,021 hospitals between 2003 and 2007 across three conditions: pneumonia, heart attack, and heart failure. The number of hospitals using either basic or advanced EMRs grew from 24 % in 2003 to 38 % in 2006.

To read the rest of the article, please visit:
EMRs Do Not Always Mean Higher Quality Of Care, Study.